Notable gainers among liquid option names this morning include Super Micro (SMCI) $38.32 +5.17, Moderna (MRNA) $44.77 +3.66, Estee Lauder (EL) $73.95 +4.02, Builders First Source (BLDR) $187.61 +9.09, and
Notable gainers among liquid option names this morning include Super Micro (SMCI) $38.32 +5.17, Moderna (MRNA) $44.77 +3.66, Estee Lauder (EL) $73.95 +4.02, Builders First Source (BLDR) $187.61 +9.09, and
Melius Research lowered the firm’s price target on Best Buy (BBY) to $85 from $100 and keeps a Hold rating on the shares. Published first on TheFly – the ultimate
הפירמה שומרת על דירוג החזקה למניות.
Best Buy Co. (BBY) is scheduled to report 3rd quarter earnings on 11/26/2024, before the market opens. Regarding Q3 estimates, Wall Street analysts expect Best Buy Co. to post earnings
JPMorgan analyst Christopher Horvers raised the firm’s price target on Best Buy (BBY) to $117 from $111 and keeps an Overweight rating on the shares ahead of the Q3 report.